PetVivo Holdings, Inc. (PETV)
USD 0.63
(0.0%)
USD 0.63
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 11.36 Million USD | 24.52% |
| 2023 | 9.12 Million USD | 83.54% |
| 2022 | 4.97 Million USD | 153.51% |
| 2021 | 1.96 Million USD | -0.4% |
| 2020 | 1.96 Million USD | -56.16% |
| 2019 | 4.49 Million USD | 96.39% |
| 2018 | 2.28 Million USD | -86.05% |
| 2017 | 16.39 Million USD | 392.96% |
| 2016 | 3.32 Million USD | 176.75% |
| 2015 | 1.2 Million USD | -96.75% |
| 2014 | 36.97 Million USD | 44769.35% |
| 2013 | 82.4 Thousand USD | -19.53% |
| 2012 | 102.4 Thousand USD | -61.03% |
| 2011 | 262.78 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 11.36 Million USD | 24.52% |
| 2024 Q1 | 2.92 Million USD | 24.48% |
| 2024 Q2 | 3.01 Million USD | 2.81% |
| 2024 Q4 | 2.87 Million USD | 12.91% |
| 2024 Q3 | 2.54 Million USD | -15.42% |
| 2023 Q4 | 2.35 Million USD | -9.7% |
| 2023 Q3 | 2.6 Million USD | 18.71% |
| 2023 Q2 | 2.19 Million USD | 11.34% |
| 2023 Q1 | 1.97 Million USD | 13.59% |
| 2023 FY | 9.12 Million USD | 83.54% |
| 2022 Q2 | 1.1 Million USD | 114.12% |
| 2022 FY | 4.97 Million USD | 153.51% |
| 2022 Q1 | 517.61 Thousand USD | 55.99% |
| 2022 Q3 | 1.6 Million USD | 45.23% |
| 2022 Q4 | 1.73 Million USD | 7.81% |
| 2021 Q2 | 811.03 Thousand USD | 84.13% |
| 2021 Q1 | 440.46 Thousand USD | -12.98% |
| 2021 FY | 1.96 Million USD | -0.4% |
| 2021 Q3 | 377.54 Thousand USD | -53.45% |
| 2021 Q4 | 331.82 Thousand USD | -12.11% |
| 2020 FY | 1.96 Million USD | -56.16% |
| 2020 Q1 | 493.72 Thousand USD | -55.39% |
| 2020 Q2 | 425.76 Thousand USD | -13.76% |
| 2020 Q3 | 543.07 Thousand USD | 27.55% |
| 2020 Q4 | 506.17 Thousand USD | -6.8% |
| 2019 Q1 | 2.09 Million USD | 119.36% |
| 2019 Q4 | 1.1 Million USD | 97.77% |
| 2019 Q3 | 559.61 Thousand USD | -23.09% |
| 2019 Q2 | 727.59 Thousand USD | -65.3% |
| 2019 FY | 4.49 Million USD | 96.39% |
| 2018 FY | 2.28 Million USD | -86.05% |
| 2018 Q4 | 956 Thousand USD | 79.4% |
| 2018 Q3 | 532.89 Thousand USD | 70.02% |
| 2018 Q1 | 484.5 Thousand USD | -28.35% |
| 2018 Q2 | 313.42 Thousand USD | -35.31% |
| 2017 FY | 16.39 Million USD | 392.96% |
| 2017 Q1 | 628.23 Thousand USD | -63.74% |
| 2017 Q4 | 676.22 Thousand USD | 35.06% |
| 2017 Q3 | 500.7 Thousand USD | -96.6% |
| 2017 Q2 | 14.74 Million USD | 2246.75% |
| 2016 Q1 | 1.08 Million USD | 539.26% |
| 2016 FY | 3.32 Million USD | 176.75% |
| 2016 Q4 | 1.73 Million USD | 438.7% |
| 2016 Q3 | 321.6 Thousand USD | 71.54% |
| 2016 Q2 | 187.47 Thousand USD | -82.71% |
| 2015 Q2 | 105.83 Thousand USD | -88.49% |
| 2015 Q1 | 919.52 Thousand USD | 657.03% |
| 2015 FY | 1.2 Million USD | -96.75% |
| 2015 Q3 | 200.81 Thousand USD | 89.74% |
| 2015 Q4 | 169.66 Thousand USD | -15.51% |
| 2014 Q4 | 121.46 Thousand USD | 318.1% |
| 2014 Q3 | 29.05 Thousand USD | -96.73% |
| 2014 Q2 | 887.76 Thousand USD | 4753.53% |
| 2014 FY | 36.97 Million USD | 44769.35% |
| 2014 Q1 | 18.29 Thousand USD | 19.09% |
| 2013 Q1 | 23.23 Thousand USD | -47.2% |
| 2013 Q2 | 22.72 Thousand USD | -2.18% |
| 2013 Q3 | 21.08 Thousand USD | -7.21% |
| 2013 Q4 | 15.35 Thousand USD | -27.16% |
| 2013 FY | 82.4 Thousand USD | -19.53% |
| 2012 Q3 | 23.65 Thousand USD | 70.68% |
| 2012 Q2 | 13.85 Thousand USD | -33.69% |
| 2012 Q1 | 20.89 Thousand USD | 50.28% |
| 2012 FY | 102.4 Thousand USD | -61.03% |
| 2012 Q4 | 44 Thousand USD | 86.03% |
| 2011 FY | 262.78 Thousand USD | 0.0% |
| 2011 Q1 | 170 Thousand USD | 0.0% |
| 2011 Q2 | 40.9 Thousand USD | -75.94% |
| 2011 Q3 | 35.85 Thousand USD | -12.34% |
| 2011 Q4 | 13.9 Thousand USD | -61.21% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -1.219% |
| Cerus Corporation | 143.15 Million USD | 92.064% |
| OrthoPediatrics Corp. | 137.01 Million USD | 91.709% |
| Talis Biomedical Corporation | 67.18 Million USD | 83.09% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 54.458% |
| Inogen, Inc. | 236.08 Million USD | 95.188% |
| Spectral AI, Inc. | 20.86 Million USD | 45.548% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 79.712% |
| CVRx, Inc. | 76.14 Million USD | 85.079% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -222.02% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 9.033% |
| Orthofix Medical Inc. | 667.42 Million USD | 98.298% |
| Venus Concept Inc. | 80.47 Million USD | 85.883% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 79.92% |
| Bioventus Inc. | 409.91 Million USD | 97.229% |
| BrainsWay Ltd. | 28.01 Million USD | 59.452% |
| Envoy Medical, Inc. | 17.89 Million USD | 36.524% |
| electroCore, Inc. | 32.03 Million USD | 64.532% |
| IceCure Medical Ltd | 16.87 Million USD | 32.68% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 73.226% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 35.571% |
| MaxCyte, Inc. | 84.84 Million USD | 86.61% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | 8.467% |
| Nexalin Technology, Inc. | 5.78 Million USD | -96.509% |
| PAVmed Inc | 64.82 Million USD | 82.475% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 77.758% |
| RxSight, Inc. | 103.85 Million USD | 89.06% |
| Sight Sciences, Inc. | 126.44 Million USD | 91.015% |
| SI-BONE, Inc. | 156.35 Million USD | 92.734% |
| TELA Bio, Inc. | 84.18 Million USD | 86.505% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 83.783% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 94.414% |
| LivaNova PLC | 843.54 Million USD | 98.653% |
| 908 Devices Inc. | 68.08 Million USD | 83.312% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 97.651% |
| Nemaura Medical Inc. | 7.13 Million USD | -59.142% |
| NeuroPace, Inc. | 75.29 Million USD | 84.912% |
| LENSAR, Inc. | 33.33 Million USD | 65.92% |
| Apyx Medical Corporation | 51.01 Million USD | 77.732% |
| Cutera, Inc. | 197.72 Million USD | 94.254% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 54.155% |
| BioSig Technologies, Inc. | 28.53 Million USD | 60.179% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 94.067% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 68.495% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 98.642% |
| Axonics, Inc. | 270.2 Million USD | 95.795% |
| Outset Medical, Inc. | 198.77 Million USD | 94.284% |
| IRIDEX Corporation | 31.81 Million USD | 64.29% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 93.696% |
| IRadimed Corporation | 30.12 Million USD | 62.285% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -33.156% |
| INVO Bioscience, Inc. | 7.85 Million USD | -44.664% |
| Telesis Bio, Inc. | 63.48 Million USD | 82.106% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 88.461% |
| Varex Imaging Corporation | 224.8 Million USD | 94.946% |
| Quipt Home Medical Corp. | 148.66 Million USD | 92.358% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 3.089% |
| Pulmonx Corporation | 112.68 Million USD | 89.918% |
| Dynatronics Corporation | 9.9 Million USD | -14.663% |
| Modular Medical, Inc. | 17.52 Million USD | 35.188% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 43.722% |
| Semler Scientific, Inc. | 38.94 Million USD | 70.828% |
| InMode Ltd. | 215.68 Million USD | 94.733% |
| Bruker Corporation | 1.07 Billion USD | 98.945% |
| Cytosorbents Corporation | 48.33 Million USD | 76.496% |
| DexCom, Inc. | 1.69 Billion USD | 99.328% |
| Align Technology, Inc. | 2.07 Billion USD | 99.453% |
| Viveve Medical, Inc. | 22.17 Million USD | 48.763% |
| ZimVie Inc. | 275.12 Million USD | 95.871% |
| Movano Inc. | 29.69 Million USD | 61.735% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 91.724% |
| Nexalin Technology, Inc. | 5.78 Million USD | -96.509% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -222.02% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 98.109% |
| Profound Medical Corp. | 33.6 Million USD | 66.191% |
| Insulet Corporation | 939.9 Million USD | 98.791% |
| enVVeno Medical Corporation | 25.23 Million USD | 54.985% |
| Surmodics, Inc. | 98.69 Million USD | 88.489% |
| iCAD, Inc. | 22.22 Million USD | 48.882% |
| Nuwellis, Inc. | 22.61 Million USD | 49.76% |
| Biotricity, Inc. | 17.18 Million USD | 33.889% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 97.452% |
| Aethlon Medical, Inc. | 12.27 Million USD | 7.466% |
| InspireMD, Inc. | 22.95 Million USD | 50.497% |
| PAVmed Inc. | 64.82 Million USD | 82.475% |
| BIOLASE, Inc. | 34.66 Million USD | 67.223% |
| Beyond Air, Inc. | 61.7 Million USD | 81.587% |
| FONAR Corporation | 28.6 Million USD | 60.283% |
| AxoGen, Inc. | 149.33 Million USD | 92.392% |
| Vivani Medical, Inc. | 26.96 Million USD | 57.868% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 93.585% |
| Inari Medical, Inc. | 448.59 Million USD | 97.467% |
| UFP Technologies, Inc. | 58.08 Million USD | 80.442% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -130.556% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -79.809% |
| Tenon Medical, Inc. | 16.96 Million USD | 33.045% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -53.671% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 74.24% |
| AdaptHealth Corp. | 1.07 Billion USD | 98.946% |
| Sintx Technologies, Inc. | 15.2 Million USD | 25.262% |
| NanoVibronix, Inc. | 4.97 Million USD | -128.451% |
| Quanterix Corporation | 118.1 Million USD | 90.38% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 3.089% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 21.335% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 97.107% |
| TransMedics Group, Inc. | 182.82 Million USD | 93.786% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 59.519% |
| NeuroMetrix, Inc. | 11.09 Million USD | -2.36% |
| Hyperfine, Inc. | 52.87 Million USD | 78.513% |
| Establishment Labs Holdings Inc. | 172 Million USD | 93.395% |
| Biomerica, Inc. | 6.97 Million USD | -62.81% |
| Bone Biologics Corporation | 9.42 Million USD | -20.497% |
| AVITA Medical, Inc. | 80.77 Million USD | 85.936% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -10.18% |
| Silk Road Medical, Inc | 186.35 Million USD | 93.904% |